复星医药：GCK-01细胞注射液、XS-02胶囊临床试验获批准

中国地震台网自动测定：03月07日18时06分在青海玉树州杂多县附近（北纬33.53度，东经93.05度）发生5.2级左右地震，最终结果以正式速报为准。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/408/w690h518/20240307/5bb1-f121e52ea11192157206d0bf6fbe2b72.jpg"]},"commentid":"live:finance-152-3519563:0","compere_id":0,"creator":"mingyu@staff.sina.com.cn","mender":"mingyu@staff.sina.com.cn","create_time":"2024-03-07 18:12:08","update_time":"2024-03-07 18:12:23","is_need_check":"0","check_time":"1970-01-01 08:00:01","check_status":"1","check_user":"","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[],"needPushWB":false,"needCMSLink":true,"needCalender":false}","old_live_cid":"0","tab":"","is_repeat":"0","tag":[{"id":"8","name":"其他"},{"id":"9","name":"焦点"},{"id":"201","name":"首发"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":3519562,"zhibo_id":152,"type":0,"rich_text":"【复星医药：GCK-01细胞注射液、XS-02胶囊临床试验获批准】控股子公司上海精缮生物科技有限责任公司于近日收到国家药品监督管理局关于同意GCK-01细胞注射液用于治疗复发或化疗耐药的滤泡性淋巴瘤的临床试验批准。精缮科技拟于条件具备后于中国境内（不包括港澳台地区，下同）开展该新药I期临床试验。该新药为集团自主研发的细胞治疗药物，属于1类创新型治疗用生物制品，拟与抗体联用治疗多种血液瘤和实体瘤。